1 results match your criteria: "Mount Sinai Medical Center and New York City Health and Hospitals[Affiliation]"
The use of bevacizumab in pediatric retinal and choroidal disease: A review.
Eur J Ophthalmol
May 2019
3 Department of Ophthalmology, Icahn School of Medicine, Mount Sinai Medical Center and New York City Health and Hospitals, New York, NY, USA.
The use of intravitreal bevacizumab in pediatric retinal and uveitic disease has become more widespread over the past decade. This article serves to outline the rationale underlying the use of intravitreal bevacizumab, and which disease entities it should be appropriately thought of as a primary or solo therapy, as opposed to an adjuvant one. Also presented is the relevant literature regarding each of these retinopathies.
View Article and Find Full Text PDF